Remus Pharmaceuticals Ltd

Growth Ratio Summary

Growth Score : 6.00

The company demonstrates strong growth in operating profit, EPS, and assets, signaling promising expansion and potential for enhanced shareholder value. However, low revenue and net income growth rates indicate areas needing attention to ensure balanced and sustainable growth. These strengths suggest a positive trajectory for the company's future. The company's growth in operating profit, EPS, and assets can lead to increased shareholder value.

Financial Ratio Summary

Financial Score : 4.20

The company's financial ratios present a mixed picture. While capital expenditures management is strong, low adjusted EPS, cash EPS, book value per share, and dividend per share indicate areas needing improvement. These factors suggest a need to enhance overall financial performance. The weighted average calculation highlights the impact of the stronger capital expenditure metric.

Profitability Ratio Summary

Profitability Score : 4.60

The company's profitability ratios are mixed. Strong ROCE and ROA are offset by low gross profit, operating, and net margins, indicating potential weaknesses in revenue generation and cost control. This suggests a need to improve overall profitability. The weighted average calculation highlights the impact of the stronger ROCE and ROA values.

Efficiency Ratio Summary

Efficiency Score : 4.67

The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days suggest effective management, low turnover ratios across fixed assets, inventory, receivables, and capital indicate potential issues in asset utilization. These inefficiencies could hinder the company's ability to maximize profits and returns. The weighted average calculation highlights the impact of current inefficiencies.

Coverage Ratio Summary

Coverage Score : 6.80

The company demonstrates a strong ability to cover its interest expenses but shows weakness in equity dividend coverage. While the interest coverage ratio suggests financial stability, the lack of equity dividend coverage may concern shareholders. This indicates a need to balance debt obligations with shareholder returns. The weighted average calculation highlights the disproportionate impact of interest coverage on the overall score.

Solvency Ratio Summary

Solvency Score : 10.00

The company exhibits a strong solvency position, suggesting a stable capital structure and a low risk of financial distress. This indicates a healthy balance between debt and equity, enabling the company to manage its long-term obligations effectively. This stability provides a solid foundation for future growth and investment. However, it is important to maintain this balance and avoid excessive reliance on debt.

Liquidity Ratio Summary

Liquidity Score : 2.00

The company's liquidity position is weak, suggesting potential difficulties in meeting its short-term obligations. This could hinder its ability to invest in growth opportunities and respond to unexpected financial challenges. While the company may have sufficient assets, their ability to convert those assets quickly into cash is questionable. The weighted average calculation, heavily influenced by recent performance, amplifies the impact of current liquidity struggles.